Temozolomide Plus Radiotherapy Improves Survival in Non-Co-Deleted Glioma
Combination treatment of temozolomide plus radiotherapy improves survival in non-co-deleted gliomas.
PVSRIPO is a prototypic oncolytic recombinant polio virus vaccine that recognizes the poliovirus receptor CD155, which is widely expressed in neoplastic cells of solid tumors.
Participants receiving TTFields with temozolomide experienced significantly longer deterioration-free survival for global health vs those receiving temozolomide only.
The FDA has granted full approval of Avastin for the treatment of glioblastoma.